Delivery Order SPE2DB20D1100-SPE2DB23FC6V0

Award Date 7/20/23
Potential Completion Date 7/21/23
Potential Value $242
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,232 to AmerisourceBergen Drug Corporation for the supply of 30 tablets of 400mg Imatinib Mesylate. The place of performance will be AmerisourceBergen's facility located in Conshohocken, Pennsylvania. The period of performance is limited to a single day, August 15, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any...
The Defense Logistics Agency awarded a $499 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, fulfilling the agency's requirements under the contract which runs from July 25 to July 26, 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to procure pharmaceuticals and medical supplies in support of its...
This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corporation $599 for 400 mg tablets of Imatinib Mesylate. The firm fixed price order is for 30 tablets and requires delivery by October 20, 2023. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this order placed under an existing vehicle by the DLA to procure pharmaceutical products in support of its mission to provide logistics support to the U.S. military and...
The Defense Logistics Agency awarded a $62,130 delivery order to Amerisourcebergen Drug Corporation for Imatinib Mesylate 100mg tablets. Under this firm fixed price contract, Amerisourcebergen will provide 90 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 28, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Prime Vendor program to support the medical readiness...
The Defense Logistics Agency awarded a $645.52 delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 30 tablets of 400mg Imatinib Mesylate. The prime contractor will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania under a firm fixed price contract running from August 14-15, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the U.S. military and...
The Defense Logistics Agency awarded a $1,194 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. Under this order, Amerisourcebergen will deliver 30 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 21, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen likely supports DLA's mission to provide medical supplies and equipment to military treatment facilities...
This delivery order for $242 from the Defense Logistics Agency to Amerisourcebergen Drug Corp is for 400 mg tablets of Imatinib Mesylate. The order is for 30 tablets and is a firm fixed price contract with performance in Conshohocken, Pennsylvania. The completion date is October 20, 2023. No set-aside designation was used for this order, which is associated with the Defense Logistics Agency's mission to provide logistics support for the Department of Defense and foreign military partners.
Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $4,433.72 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 400mg Imatinib Mesylate tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The contract period of performance spans October 21 to October 22, 2021. No subcontractors or set aside designations were identified. This delivery order was issued against an...
The Defense Logistics Agency Troop Support Medical awarded a $114,870 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg tablets of imatinib mesylate. The delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA Troop Support and its customers. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all items to be delivered by August 28, 2023. No...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $4,406.04 to Amerisourcebergen Drug Corporation for 400 mg tablets of Imatinib Mesylate. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver 30 tablets from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements by August 31, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FC6V0
    Delivery Order

The Defense Logistics Agency awarded a $242,070 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 30 boxes of 400mg Imatinib Mesylate tablets. The place of performance is AmerisourceBergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 20-21, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill requirements for oncology medications in support of DOD health programs. No set aside designation or subcontractors were identified.

Generated 12/18/23, 7:59 AM